# Adma Biologics reiterates at least $530M 2026 revenue and raises minimum adjusted EBITDA to at least $275M as ASCENIV demand accelerates

- Source: Seeking Alpha Market Currents
- Published: 2026-11-05T05:09:12+00:00
- Category: Markets
- Original: https://seekingalpha.com/news/4666170-adma-biologics-reiterates-at-least-530m-2026-revenue-and-raises-minimum-adjusted-ebitda-to-at?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
- Canonical: https://groundlevelnews.com/story/adma-biologics-reiterates-at-least-530m-2026-revenue-and-raises-minimu-c57094/

Read the full report from the original publisher.

_Ground Level News shows a short summary only; the full article and all rights belong to Seeking Alpha Market Currents._